BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kryeziu K, Bruun J, Guren TK, Sveen A, Lothe RA. Combination therapies with HSP90 inhibitors against colorectal cancer. Biochim Biophys Acta Rev Cancer 2019;1871:240-7. [PMID: 30708039 DOI: 10.1016/j.bbcan.2019.01.002] [Cited by in Crossref: 29] [Cited by in F6Publishing: 27] [Article Influence: 9.7] [Reference Citation Analysis]
Number Citing Articles
1 El-shafey HW, Gomaa RM, El-messery SM, Goda FE. Synthetic approaches, anticancer potential, HSP90 inhibition, multitarget evaluation, molecular modeling and apoptosis mechanistic study of thioquinazolinone skeleton: Promising antibreast cancer agent. Bioorganic Chemistry 2020;101:103987. [DOI: 10.1016/j.bioorg.2020.103987] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
2 Pinzi L, Foschi F, Christodoulou MS, Passarella D, Rastelli G. Design and Synthesis of Hsp90 Inhibitors with B-Raf and PDHK1 Multi-Target Activity. ChemistryOpen 2021;10:1177-85. [PMID: 34633754 DOI: 10.1002/open.202100131] [Reference Citation Analysis]
3 Díaz-Díaz A, Roca-Lema D, Casas-Pais A, Romay G, Colombo G, Concha Á, Graña B, Figueroa A. Heat Shock Protein 90 Chaperone Regulates the E3 Ubiquitin-Ligase Hakai Protein Stability. Cancers (Basel) 2020;12:E215. [PMID: 31952268 DOI: 10.3390/cancers12010215] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
4 Ernst A, Hennel R, Krombach J, Kapfhammer H, Brix N, Zuchtriegel G, Uhl B, Reichel CA, Frey B, Gaipl US, Winssinger N, Shirasawa S, Sasazuki T, Sperandio M, Belka C, Lauber K. Priming of Anti-tumor Immune Mechanisms by Radiotherapy Is Augmented by Inhibition of Heat Shock Protein 90. Front Oncol 2020;10:1668. [PMID: 32984042 DOI: 10.3389/fonc.2020.01668] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
5 Abi Zamer B, El-Huneidi W, Eladl MA, Muhammad JS. Ins and Outs of Heat Shock Proteins in Colorectal Carcinoma: Its Role in Carcinogenesis and Therapeutic Perspectives. Cells 2021;10:2862. [PMID: 34831085 DOI: 10.3390/cells10112862] [Reference Citation Analysis]
6 Kubra KT, Akhter MS, Uddin MA, Barabutis N. P53 versus inflammation: an update. Cell Cycle 2020;19:160-2. [PMID: 31880200 DOI: 10.1080/15384101.2019.1708575] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 4.3] [Reference Citation Analysis]
7 Liu Q, Wang Z, Zhou X, Tang M, Tan W, Sun T, Wang Y, Deng Y. miR-485-5p/HSP90 axis blocks Akt1 phosphorylation to suppress osteosarcoma cell proliferation and migration via PI3K/AKT pathway. J Physiol Biochem 2020;76:279-90. [PMID: 32100243 DOI: 10.1007/s13105-020-00730-8] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 2.5] [Reference Citation Analysis]
8 Gabbasov R, Benrubi ID, O'Brien SW, Krais JJ, Johnson N, Litwin S, Connolly DC. Targeted blockade of HSP90 impairs DNA-damage response proteins and increases the sensitivity of ovarian carcinoma cells to PARP inhibition. Cancer Biol Ther 2019;20:1035-45. [PMID: 30929564 DOI: 10.1080/15384047.2019.1595279] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.7] [Reference Citation Analysis]
9 Solopov P, Biancatelli RMLC, Marinova M, Dimitropoulou C, Catravas JD. The HSP90 Inhibitor, AUY-922, Ameliorates the Development of Nitrogen Mustard-Induced Pulmonary Fibrosis and Lung Dysfunction in Mice. Int J Mol Sci 2020;21:E4740. [PMID: 32635192 DOI: 10.3390/ijms21134740] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 5.0] [Reference Citation Analysis]
10 Jinka S, Rachamalla HK, Bhattacharyya T, Sridharan K, Sekhar Jaggarapu MMC, Yakati V, Banerjee R. Glucocorticoid receptor-targeted liposomal delivery system for delivering small molecule ESC8 and anti-miR-Hsp90 gene construct to combat colon cancer. Biomed Mater 2021;16:024105. [PMID: 33434900 DOI: 10.1088/1748-605X/abdb08] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
11 Liu Y, Wu L, Lu H, Wu E, Ni J, Zhou X. Enhancing the Therapeutic Efficacy of KRASG12C Inhibitors in Lung Adenocarcinoma Cell Models by Cotargeting the MAPK Pathway or HSP90. J Oncol 2021;2021:2721466. [PMID: 34858498 DOI: 10.1155/2021/2721466] [Reference Citation Analysis]
12 García-Minguillán O, Maestú C. 30 Hz, Could It Be Part of a Window Frequency for Cellular Response? Int J Mol Sci 2021;22:3642. [PMID: 33807400 DOI: 10.3390/ijms22073642] [Reference Citation Analysis]
13 Borgo C, Ruzzene M. Role of protein kinase CK2 in antitumor drug resistance. J Exp Clin Cancer Res 2019;38:287. [PMID: 31277672 DOI: 10.1186/s13046-019-1292-y] [Cited by in Crossref: 30] [Cited by in F6Publishing: 30] [Article Influence: 10.0] [Reference Citation Analysis]
14 Zhang S, Guo S, Li Z, Li D, Zhan Q. High expression of HSP90 is associated with poor prognosis in patients with colorectal cancer. PeerJ 2019;7:e7946. [PMID: 31687275 DOI: 10.7717/peerj.7946] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
15 Abumustafa W, Zamer BA, Khalil BA, Hamad M, Maghazachi AA, Muhammad JS. Protein arginine N-methyltransferase 5 in colorectal carcinoma: Insights into mechanisms of pathogenesis and therapeutic strategies. Biomed Pharmacother 2021;145:112368. [PMID: 34794114 DOI: 10.1016/j.biopha.2021.112368] [Reference Citation Analysis]
16 Khan M, Zhao Z, Arooj S, Fu Y, Liao G. Soluble PD-1: Predictive, Prognostic, and Therapeutic Value for Cancer Immunotherapy. Front Immunol 2020;11:587460. [PMID: 33329567 DOI: 10.3389/fimmu.2020.587460] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
17 Zhang Y, VanHecke GC, Ahn YH, Proby CM, Dinkova-Kostova AT. Sulfoxythiocarbamate S-4 inhibits HSP90 in human cutaneous squamous cell carcinoma cells. Eur J Pharmacol 2020;889:173609. [PMID: 33031796 DOI: 10.1016/j.ejphar.2020.173609] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
18 Altinok S, Sanchez-Hodge R, Stewart M, Smith K, Schisler JC. With or without You: Co-Chaperones Mediate Health and Disease by Modifying Chaperone Function and Protein Triage. Cells 2021;10:3121. [PMID: 34831344 DOI: 10.3390/cells10113121] [Reference Citation Analysis]
19 Azwar S, Seow HF, Abdullah M, Faisal Jabar M, Mohtarrudin N. Recent Updates on Mechanisms of Resistance to 5-Fluorouracil and Reversal Strategies in Colon Cancer Treatment. Biology (Basel) 2021;10:854. [PMID: 34571731 DOI: 10.3390/biology10090854] [Reference Citation Analysis]
20 Uddin MA, Akhter MS, Kubra KT, Barabutis N. Hsp90 inhibition protects brain endothelial cells against LPS-induced injury. Biofactors 2022. [PMID: 35266593 DOI: 10.1002/biof.1833] [Reference Citation Analysis]
21 Marinova M, Solopov P, Dimitropoulou C, Colunga Biancatelli RML, Catravas JD. Post-treatment with a heat shock protein 90 inhibitor prevents chronic lung injury and pulmonary fibrosis, following acute exposure of mice to HCl. Exp Lung Res 2020;46:203-16. [PMID: 32400213 DOI: 10.1080/01902148.2020.1764148] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 5.0] [Reference Citation Analysis]
22 Ji F, Zhou M, Sun Z, Jiang Z, Zhu H, Xie Z, Ouyang X, Zhang L, Li L. Integrative proteomics reveals the role of E3 ubiquitin ligase SYVN1 in hepatocellular carcinoma metastasis. Cancer Commun (Lond) 2021. [PMID: 34196494 DOI: 10.1002/cac2.12192] [Reference Citation Analysis]
23 Epp-Ducharme B, Dunne M, Fan L, Evans JC, Ahmed L, Bannigan P, Allen C. Heat-activated nanomedicine formulation improves the anticancer potential of the HSP90 inhibitor luminespib in vitro. Sci Rep 2021;11:11103. [PMID: 34045581 DOI: 10.1038/s41598-021-90585-w] [Reference Citation Analysis]
24 Ma YS, Wu ZJ, Zhang HW, Cai B, Huang T, Long HD, Xu H, Zhao YZ, Yin YZ, Xue SB, Li L, Liu CL, Xie RT, Tian LL, Liu JB, Wu XM, Fu D. Dual Regulatory Mechanisms of Expression and Mutation Involving Metabolism-Related Genes FDFT1 and UQCR5 during CLM. Mol Ther Oncolytics 2019;14:172-8. [PMID: 31236441 DOI: 10.1016/j.omto.2019.04.008] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 3.3] [Reference Citation Analysis]
25 Lee Y, Fong SY, Shon J, Zhang SL, Brooks R, Lahens NF, Chen D, Dang CV, Field JM, Sehgal A. Time-of-day specificity of anticancer drugs may be mediated by circadian regulation of the cell cycle. Sci Adv 2021;7:eabd2645. [PMID: 33579708 DOI: 10.1126/sciadv.abd2645] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 7.0] [Reference Citation Analysis]
26 Zeng J, He SL, Li LJ, Wang C. Hsp90 up-regulates PD-L1 to promote HPV-positive cervical cancer via HER2/PI3K/AKT pathway. Mol Med 2021;27:130. [PMID: 34666670 DOI: 10.1186/s10020-021-00384-2] [Reference Citation Analysis]
27 Lettini G, Pietrafesa M, Lepore S, Maddalena F, Crispo F, Sgambato A, Esposito F, Landriscina M. Heat shock proteins in thyroid malignancies: Potential therapeutic targets for poorly-differentiated and anaplastic tumours? Mol Cell Endocrinol 2020;502:110676. [PMID: 31812782 DOI: 10.1016/j.mce.2019.110676] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
28 Mathien S, Tesnière C, Meloche S. Regulation of Mitogen-Activated Protein Kinase Signaling Pathways by the Ubiquitin-Proteasome System and Its Pharmacological Potential. Pharmacol Rev 2021;73:263-96. [PMID: 34732541 DOI: 10.1124/pharmrev.120.000170] [Reference Citation Analysis]
29 Albakova Z, Mangasarova Y, Sapozhnikov A. Heat Shock Proteins in Lymphoma Immunotherapy. Front Immunol 2021;12:660085. [PMID: 33815422 DOI: 10.3389/fimmu.2021.660085] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
30 Song D, Guo M, Xu S, Song X, Bai B, Li Z, Chen J, An Y, Nie Y, Wu K, Wang S, Zhao Q. HSP90-dependent PUS7 overexpression facilitates the metastasis of colorectal cancer cells by regulating LASP1 abundance. J Exp Clin Cancer Res 2021;40:170. [PMID: 33990203 DOI: 10.1186/s13046-021-01951-5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
31 Wang R, Alvarez DA, Crouch BT, Pilani A, Lam C, Zhu C, Hughes P, Katz D, Haystead T, Ramanujam N. Understanding the sources of errors in ex vivo Hsp90 molecular imaging for rapid-on-site breast cancer diagnosis. Biomed Opt Express 2021;12:2299-311. [PMID: 33996230 DOI: 10.1364/BOE.418818] [Reference Citation Analysis]
32 Mortensen ACL, Mohajershojai T, Hariri M, Pettersson M, Spiegelberg D. Overcoming Limitations of Cisplatin Therapy by Additional Treatment With the HSP90 Inhibitor Onalespib. Front Oncol 2020;10:532285. [PMID: 33102211 DOI: 10.3389/fonc.2020.532285] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
33 Ma YS, Li W, Liu Y, Shi Y, Lin QL, Fu D. Targeting Colorectal Cancer Stem Cells as an Effective Treatment for Colorectal Cancer. Technol Cancer Res Treat 2020;19:1533033819892261. [PMID: 32748700 DOI: 10.1177/1533033819892261] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
34 Rodrigues Moita AJ, Bandolik JJ, Hansen FK, Kurz T, Hamacher A, Kassack MU. Priming with HDAC Inhibitors Sensitizes Ovarian Cancer Cells to Treatment with Cisplatin and HSP90 Inhibitors. Int J Mol Sci 2020;21:E8300. [PMID: 33167494 DOI: 10.3390/ijms21218300] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
35 Das JK, Xiong X, Ren X, Yang JM, Song J. Heat Shock Proteins in Cancer Immunotherapy. J Oncol 2019;2019:3267207. [PMID: 31885572 DOI: 10.1155/2019/3267207] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 4.3] [Reference Citation Analysis]